science
FDA Encourages Shift From Animal Testing Models
The FDA is urging pharmaceutical companies to reduce reliance on animal testing. Betts Lacroix stated that current technology does not yet support complete replacement of animal models.
May 19, 7:16 PM·1m read1 source
fda.govAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The FDA has directed companies to move away from animal models in drug development. The agency said the change aims to incorporate newer testing methods where possible. Betts Lacroix said the technology is not yet advanced enough to entirely abandon animal models. Lacroix added that some animal testing remains necessary for safety and efficacy data.
The FDA continues to accept data from both traditional and alternative testing methods. Companies may submit results from non-animal models when the data meet agency standards.
Drug developers are evaluating how to integrate new testing technologies while maintaining compliance. No specific timeline for full transition has been announced.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationModerate · 1 source
